WINNIPEG, MB, June 20, 2024 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the "Company") (TSXV: WAVE), a Canadian pharmaceutical company, is pleased to announce the voting results for the election of directors at its annual and special meeting of shareholders held earlier today (the "Meeting"). Each of the four nominees listed in Company's management information circular dated May 2, 2024, namely Dr. Albert Friesen, P. Marcus Enns, James Kinley and Larry Thiessen, was elected as a director of Waverley Pharma to hold office until the next annual meeting of shareholders or until their successor is duly elected. All matters to be acted upon at the Meeting, including the election of directors and approval of the Company's rolling stock option plan, were approved, receiving votes for totalling greater than 99%.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
